Financial Security Advisor’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$800K Buy
3,178
+11
+0.3% +$2.37K 0.13% 72
2026
Q1
$689K Buy
3,167
+9
+0.3% +$2K 0.13% 71
2025
Q4
$722K Sell
3,158
-45
-1% -$10.3K 0.14% 65
2025
Q3
$742K Buy
3,203
+26
+0.8% +$5.29K 0.16% 61
2025
Q2
$590K Buy
3,177
+158
+5% +$29.4K 0.14% 63
2025
Q1
$632K Sell
3,019
-6
-0.2% -$1.17K 0.16% 57
2024
Q4
$538K Sell
3,025
-75
-2% -$13.8K 0.14% 61
2024
Q3
$612K Sell
3,100
-62
-2% -$11.6K 0.15% 55
2024
Q2
$542K Buy
3,162
+93
+3% +$15.4K 0.18% 55
2024
Q1
$559K Sell
3,069
-102
-3% -$17.6K 0.2% 53
2023
Q4
$491K Buy
3,171
+137
+5% +$20K 0.19% 54
2023
Q3
$452K Buy
+3,034
New +$445K 0.21% 56

Other funds holding ABBV

Financial Security Advisor's ABBV Position: Q2 2026 in Review

Financial Security Advisor increased its AbbVie (ABBV) stake by 0.35% in Q2 2026, buying an estimated $2.37K and bringing the position to 3,178 shares worth $800K. The position accounts for 0.13% of the portfolio, ranked #72.

Financial Security Advisor first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Financial Security Advisor held 3,178 shares of AbbVie worth $800K as of Q2 2026.
  • Financial Security Advisor bought 11 AbbVie shares in Q2 2026, an estimated $2.37K.
  • AbbVie made up 0.13% of Financial Security Advisor's portfolio in Q2 2026, its #72 holding.
  • Financial Security Advisor first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Financial Security Advisor's 13F filing for Q2 2026, filed 11 Aug 2026.